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Having an extremely toxic compound for humans 
and most animals, paraquat (PQ) is known as one 
of the most frequently used herbicides. 
Accordingly, PQ poisoning has been recognized as 
a serious medical problem across the world, with a 
severe case fatality rate (CFR) (1, 2). In this respect; 
accidental or intentional ingestion of PQ, even in a 
small amount, can be significantly associated with 
poor clinical prognosis and increased mortality. 
Moreover; inherent toxicity of PQ, absence of 
specific antidotes, as well as lack of effective 
treatments have been principally attributed to high 
fatality of PQ poisoning. Once PQ is ingested, it can 
be absorbed through skin and the digestive and 
respiratory system and often progresses to multi-
organ failure, particularly the lungs as the main 
target. In this respect, PQ accumulates 
predominantly in the lungs and can lead to lung 
fibrosis, pneumonitis, and consequently 
respiratory failure and death (2, 3). Given the 
nonexistence of specific and widely accepted 
guidelines for treatment of PQ poisoning, a range of 
conservative therapeutic modalities have been 
proposed and administered by clinicians to 
moderate PQ absorption and to prevent organ 
failure in these patients. In spite of this, PQ-induced 
mortality rate is high and disappointing (1, 3). 
Although the exact mechanism of PQ-induced 
toxicity has not been fully elucidated, inflammation 
and oxidative stress have been proposed as the 
most widely accepted ones. Therefore, it is 
reasonable to assume that use of antioxidants may 
reduce and protect against PQ-induced toxicity (2, 
3). Recently, Silymarin has been evaluated and 
advocated as a potential promising treatment 
modality for PQ poisoning. As a polyphenolic 
flavonoid, Silymarin is extracted from seeds and 
fruits of milk thistle (also known as Silybum 
marianum). It has been previously confirmed that 
Silymarin has anti-inflammatory and antioxidant 
activity, without any significant adverse effects (4, 
5). In an in-vitro study by Liu et al., Silymarin had 
significantly reduced PQ-induced macrophage 
cytotoxicity through suppressing inflammatory 
and oxidative responses (1). Moreover, in another 
in-vitro study; Podder et al. had confirmed the 
protective effect of Silymarin against PQ-induced 
cytotoxicity on human lung adenocarcinoma cell 
line (4). To add this, Zaho et al. in an in-vivo and in-
vitro study had demonstrated the significant 
protective effect of Silymarin against PQ-induced 
lung injury via reducing oxidative stress and 
inflammatory response (2). Furthermore, in a 
study on rats, the protective effect of Silymarin 
against PQ-induced hepatotoxicity had been 
validated (3).  
In sum; considering the high mortality rate of PQ 
poisoning and lack of adequate and efficacious 
standard treatments for this condition as well as 
the crucial role of inflammation and oxidative 
stress in pathogenesis of PQ-induced toxicity and 
given the potential anti-inflammatory and anti-
oxidative properties of Silymarin in reducing PQ-
induced toxicity, it seems that Silymarin can be 
employed as a safe and effective therapeutic 
modality for patients with PQ poisoning. However, 
further well-designed clinical trials are needed to 
evaluate the efficacy and the optimal dose of 
Silymarin in treatment of patients with PQ 
poisoning. 
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